We are live on ! Find out more
NVNOW

enVVeno Medical Corporation Warrants
NVNOW

Delisted

NVNOW was delisted on the 26th of May, 2023.

Back to rankings

1 hedge funds and large institutions have $9K invested in enVVeno Medical Corporation Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$10.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$9K +$10.4K +10,602 New

NVNOW Hedge Fund Activity: Q2 2018 in Review

1 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q2 2018, worth a combined $9K.

Buyers outnumbered sellers: 1 fund opened new NVNOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $10.4K.

  • 1 institutional investor held enVVeno Medical Corporation Warrants (NVNOW) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $9K of enVVeno Medical Corporation Warrants stock for Q2 2018.
  • 1 fund opened new enVVeno Medical Corporation Warrants positions in Q2 2018 and 0 closed out, a net change of +1 holder.
  • The largest enVVeno Medical Corporation Warrants buyer in Q2 2018 was UBS Group, an estimated $10.4K added.

Based on aggregated 13F filings for Q2 2018.